| Literature DB >> 35181439 |
Xiao Zhuang1, Bing Zhan1, Yufeng Jia1, Chaoze Li1, Nan Wu1, Ming Zhao2, Nuo Chen1, Yaxin Guo1, Yingxin Du1, Yi Zhang1, Baihui Cao1, Yan Li3, Faliang Zhu1, Chun Guo1, Qun Wang1, Yuan Li4, Lining Zhang5.
Abstract
Hyper-inflammatory reaction plays a crucial role in the pathophysiology of depression and anxiety disorders. However, the mechanisms underlying inflammation-induced anxiety changes remain poorly understood. Here, we showed that in the lipopolysaccharide (LPS)-induced anxiety model, Interleukin (IL)-33, a member of the IL-1 family, was up-regulated in the basolateral amygdala, and IL-33 deficiency prevent anxiety-like behavior. Overexpression of IL-33 in amygdalar astrocytes led to anxiety-like response via repressing brain-derived neurotrophic factor (BDNF) expression. Mechanically, IL-33 suppressed BDNF expression through NF-κB pathway to impair GABAergic transmission in the amygdala and NF-κB inhibitor abolished the effect of IL-33 on anxiety. Administration of an inverse GABAA receptor agonist increased the anxiety of IL-33- deficient mice. These results reveal that inflammatory response can activate anxiogenic circuits by suppressing BDNF and GABAergic neurons transmission, suggesting that IL-33 in basolateral amygdalar is a linker between inflammation and anxiety.Entities:
Keywords: Amygdala; Anxiety; BDNF; IL-33
Mesh:
Substances:
Year: 2022 PMID: 35181439 DOI: 10.1016/j.bbi.2022.02.019
Source DB: PubMed Journal: Brain Behav Immun ISSN: 0889-1591 Impact factor: 7.217